Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis

Clinical and Vaccine Immunology

Volumn 16, Issue 7, 2009, Pages 991-998

  Hasan, Zahra ^a   Jamil, Bushra ^a,b   Ashraf, Mussarat ^a   Islam, Muniba ^a   Dojki, Maqboola ^a   Irfan, Muhammad ^b   Hussain, Rabia ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; CXCL9 CHEMOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; CELL LEVEL; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; YOUNG ADULT;

EID: 67650373865     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00091-09     Document Type: Article

References (51)

1. Abramo, C., K. Meijgaarden, D. Garcia, K. Franken, M. Klein, A. Kolk, S. Oliveira, T. Ottenhoff, and H. Teixeira. 2006. Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect. 8:45-51. (Pubitemid 43139291)
2. Algood, H. M. S., J. Chan, and J. L. Flynn. 2003. Chemokines and tuberculosis. Cyt. Growth Fact. Rev. 14:467-477.
3. Antas, P. R. Z., F. L. L. Cardoso, K. C. Peira, K. L. M. C. Franken, K. S. Cunha, P. Klaster, E. N. Sarno, T. H. M. Ottenhoff, and S. P. Sampaio. 2005. T cell immune response to mycobacterial antigens in Brazilian tuberculosis patients and controls. Trans. R. Soc. Trop. Med. Hyg. 99:699-707.
4. Arend, S. M., A. C. F. Engelhard, G. Groot, K. de Boer, P. Andersen, T. H. Ottenhoff, and J. T. V. Dissel. 2001. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin. Diagn. Lab. Immunol. 8:1089-1096.
5. Baldwin, S., C. D'Souza, A. Roberts, et al. 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951-2959.
6. Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin. J. Immunol. 162:3504-3511.
7. Beltan, E., L. Horgen, and N. Rastogi. 2000. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microbiol. Pathogen 28:313-318. (Pubitemid 30692477)
8. Berthet, F. X., P. B. Rasmussen, I. Rosenkrands, P. Andersen, and B. Gicquel. 1998. Mycobacterium tuberculosis operon encoding ESAT6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144:195-203.
9. Brock, I., M. E. Munck, A. K. Jensen, and P. Anderson. 2001. Performance of whole blood IFN-γ test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Lung Tuberc. Dis. 5:462-467.
10. Crofton, J. 1990. Clinical features of tuberculosis, p. 395-421. In Crofton and Douglas respiratory diseases. Blackwell Scientific, London, United Kingdom.
11. Demissie, A., E. M. S. Leyten, M. Abebe, L. Wassie, A. Aseffa, G. Abate, H. Fletcher, P. Owiafe, P. C. Hill, R. Brookes, G. Rook, A. Zulma, S. M. Arend, M. Klein, T. H. M. Ottenhoff, P. Andersen, T. M. Doherty, and VASCEL Study Group. 2006. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13:179-186. (Pubitemid 43383784)
12. Diel, R., A. Nienchaus, C. Lange, K. M. Walter, M. Forßohm, and T. Schaberg. 2006. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCGvaccinated persons. Respir. Res. 77:1-9.
13. Flynn, J. L., and J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 12:432-436.
14. Gehring, A. J., R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71:4487-4497.
15. Greenaway, C., C. Lienhardt, R. Adegbola, R. Brusasca, K. McAdam, and D. Menzies. 2005. Humoral response to Mycobacterium tuberculosis antigens in patients with tuberculosis in the Gambia. Int. J. Lung Tuberc. Dis. 9:1112-1119.
16. Harboe, M., T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen. 1996. Evidence for occurrence of the ESAT6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium novis BCG. Infect. Immun. 64:16-22. (Pubitemid 26009335)
17. Hasan, Z., B. Jamil, J. Khan, R. Ali, M. A. Khan, N. Nasir, S. Yusuf, S. Jamil, M. Irfan, and R. Hussain. 2009. Relationship between circulating levels of IFNγ, IL10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand. J. Immunol. 69:259-267.
18. Hasan, Z., C. Schlax, L. Kuhn, I. Lefkovitz, D. B. Young, J. Thole, and J. Pieters. 1997. Isolation and characterisation of the mycobacterial phagosome: segregation of the phagosome from the endosomal/lysosomal pathway. Mol. Microbiol. 24:545-553.
19. Hasan, Z., B. H. Shah, A. Mahmood, D. B. Young, and R. Hussain. 2003. The effect of mycobacterial virulence and viability on MAP kinase signaling and TNFα production by human monocytes. Tuberculosis 83:299-309. (Pubitemid 37175895)
20. Hasan, Z., I. Zaidi, B. Jamil, M. A. Khan, A. Kanji, and R. Hussain. 2005. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol. 6:14.
21. Herrera, M. T., M. Torres, D. Nevels, C. N. Perez-Redono, J. E. Ellner, E. Sada, and S. K. Schwander. 2009. Compartmentalized bronchoalveolar IFNg and IL-12 response in human pulmonary tuberculosis. Tuberculosis 89:38-47.
22. Hussain, R., R. Hasan, M. Khurshid, A. W. Sturm, J. J. Ellner, and G. Dawood. 1996. Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns. Southeast Asian J. Trop. Med. Public Health 27:1-6.
23. Hussain, R., N. Talat, F. Shahid, and G. Dawood. 2007. Longitudinal tracking of cytokine after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clin. Vaccine Immunol. 14:1578-1586.
24. Jamil, B., F. Shahid, Z. Hasan, N. Nasir, T. Razzaki, G. Dawood, and R. Hussain. 2007. Interferon γ:IL10 ratio defines the severity of disease in pulmonary and extra-pulmonary tuberculosis. Tuberculosis 87:279-287. (Pubitemid 46936246)
25. Keane, J., H. G. Remold, and H. Kornfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016-2020.
26. Kipnis, A., R. J. Basaraba, I. M. Orme, and A. M. Cooper. 2003. Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 109:547-551. (Pubitemid 36930170)
27. Lalvani, A. 2007. Diagnosing tuberculosis infection in the 21st century. Chest 131:1898-1906.
28. Lanckriet, C., D. Levy-Bruhl, E. Bingono, R. M. Siopathis, and N. Guerin. 1995. Efficacy of BCG vaccination of the newborn: evaluation by a followup study of contacts in Bangui. Int. J. Epidemiol. 24:1042-1049.
29. Locht, C., J. M. Hougardy, C. Rouanet, S. Place, and F. Mascart. 2006. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis 86:303-309.
30. Masungi, C., S. Temmerman, J. P. Van Vooren, A. Drowart, K. Pethe, F. D. Menozzi, C. Locht, and F. Mascart. 2002. Differential T and C cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 185:513-520.
31. Mazurek, G. H., S. E. Weis, P. K. Moonan, C. L. Daley, J. Bernardo, A. A. Lardizabal, R. R. Reves, S. R. Toney, L. J. Daniels, and P. A. LoBue. 2007. Prospective comparison of the tuberculin skin test and 2 whole blood interferon- γ release assays in persons with suspected tuberculosis. Clin. Infect. Dis. 45:837-845.
32. McMurray, D. 2003. Recent progress in the development and testing of vaccines against human tuberculosis. Int. J. Parasitol. 33:547-554.
33. Morosini, M., F. Meloni, A. M. Bianco, A. M. Paschetto, M. Uccelli, E. Pozzi, and A. Fietta. 2003. The assessment of IFNγ and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int. J. Lung Tuberc. Dis. 7:994-1000.
34. Orme, I. 1993. Immunity to mycobacteria. Curr. Opin. Immunol. 5:497-502.
35. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. S. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFNγ secreting CD4 T cells in Mycobacterium tuberculosisinfected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167:5217-5225.
36. Rajashree, P., G. Krishnan, and S. D. Das. 2009. Impaired phenotype and function of monocyte derived dendritic cells in pulmonary tuberculosis. Tuberculosis 89:77-83.
37. Ravn, P., M. E. Munk, A. B. Andersen, B. Lundgren, J. D. Lundgren, L. N. Nielsen, A. Kok-Jensen, P. Andersen, and K. Weldingh. 2005. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 12:491-496.
38. Roach, D. R., A. G. D. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168:4620-4627. (Pubitemid 34441368)
39. Roach, T., C. Barton, D. Chatterjee, and J. Blackwell. 1993. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J. Immunol. 150:1886-1896.
40. Ruhwald, M., T. Bodmer, C. Maier, M. Jepsen, M. B. Haaland, J. Eugen- Olsen, and P. Ravn. 2008. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J. 32:1607-1615.
41. Sahiratmadja, E., B. Alisjahbana, T. B. Boer, I. Adnan, A. Maya, H. Danusantoso, R. H. H. Nelwan, S. Markuzi, J. W. M. van der Meer, R. V. Vrevl, E. V. D. Vosse, and T. H. M. Ottenhoff. 2007. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829.
42. Saunders, B. M., and W. J. Britton. 2007. Life and death in the granuloma: immunopathology of tuberculosis. Immunol. Cell Biol. 85:103-111.
43. Schreiber, O., K. Steinwede, N. Ding, M. Srivastava, R. Maus, F. Langer, J. Prokein, S. Ehlers, T. Welte, D. M. Gunn, and U. A. Maus. 2008. Mice that overexpress CC chemokine ligand 2 in their lungs show increased protective immunity to infection with Mycobacterium bovis Bacille Calmette-Guerin. J. Infect. Dis. 198:1044-1054.
44. Scott, H. M., and J. L. Flynn. 2002. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70:5946-5954.
45. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367:1173-1180.
46. Ulrichs, T., P. Andind, S. H. E. Kaufmann, and M. E. Munk. 2000. Numbers of IFN-γ producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int. J. Lung Tuberc. Dis. 12:1181-1183.
47. Ulrichs, T., P. Anding, S. Porcelli, S. H. E. Kaufmann, and M. E. Munk. 2000. Increased numbers of ESAT6 and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect. Immun. 68:6073-6076.
48. Ulrichs, T., G. A. Kosmiadi, S. Jörg, L. Pradl, M. Titukhina, V. Mishenko, N. Gushina, and S. H. E. Kaufmann. 2005. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculosis. J. Infect. Dis. 192:89-97.
49. Weir, R. E., P. Gorak-Stolinska, S. Floyd, M. K. Lalor, S. Stenson, K. Branson, R. Blitz, A. Ben-Smith, P. E. Fine, and H. M. Dockrell. 2008. Persistence of the immune responses induced by BCG vaccination. BMC Infect. Dis. 8:9.
50. WHO. 2008. Country profile Pakistan, p. 133-136. World Health Organization, Geneva, Switzerland.
51. WHO/UNICEF. 2008. Review of national immunization coverage 1980-2007. World Health Organization, Geneva, Switzerland.